Let’s finish what Nixon started
Let’s finish what Nixon started
This is the beginning of the end of cancer…

Where Innovation Meets Investing

By opting in you are also consenting to receive RiskHedge marketing emails. You can opt-out from these at any time. Privacy Policy.

 A potential cure for Parkinson’s
AI helped researchers find five “highly potent” compounds which can stop the protein that characterizes Parkinson’s.
Taken to the AI slaughterhouse
RIP to ChatGPT’s easiest victim…
Why I’m leaving Europe
I’m out, and excited for what’s next.
The beginning of the end of cancer?
A behind-the-scenes look at April’s Disruption Investor
Imagine kissing your kids goodbye…
AI’s future hinges on crypto
What’s that screeching sound?
Welcome to euphoria
Invest like Lance Armstrong
The ultimate “middleman” killer…
Are you participating in bitcoin’s IPO?

RiskHedge contributors have been featured on:

Bloomberg
Forbes
Business Insider
CNBC
Fox Business
ABC News
Market Watch
Yahoo Finance
Seeking Alpha

Why settle for 20% gains when you can safely 2X your money in disruptive stocks that are breaking all the rules?

Claim your FREE copy of our new special report: The Great Disruptors: 3 Breakthrough Stocks Set to Double Your Money.

No thanks, I'm not interested in doubling my money

By entering your email, you're opting in to receive our free weekly investment letter that tells you about profitable opportunities in markets. We'll never send you spam, and you can opt-out at any time. Read our privacy policy here.